Gilead Sciences reports strong Q2 2025 results, driven by robust HIV drug sales, and raises full-year guidance, making it a top performer in the S&P 500 and Nasdaq 100.
Gutfeld, host of 'Gutfeld!', makes late-night debut on 'The Tonight Show' amid Trump's criticism of Fallon and other hosts.
Tesla shifts focus from in-house AI training hardware to inference chips for self-driving and robotics.
Gilead Sciences reports strong Q2 2025 results, driven by robust HIV drug sales, and raises full-year guidance, making it a top performer in the S&P 500 and Nasdaq 100.
Gutfeld, host of 'Gutfeld!', makes late-night debut on 'The Tonight Show' amid Trump's criticism of Fallon and other hosts.
Tesla shifts focus from in-house AI training hardware to inference chips for self-driving and robotics.
